GEP-NET radiomics: a systematic review and radiomics quality score assessment.
Femke C R StaalElse A AalbersbergDaphne van der VeldenErica A WilthagenMargot E T TesselaarRegina G H Beets-TanMonique MaasPublished in: European radiology (2022)
• The majority of radiomics studies in gastroenteropancreatic neuroendocrine tumours is of low quality. • Most evidence for radiomics is available for the identification of tumour grade or differentiation of gastroenteropancreatic neuroendocrine tumours from other neoplasms. • Radiomics for the prediction of response or long-term outcome in gastroenteropancreatic neuroendocrine tumours warrants further research.